Avistone Pharmaceuticals
About:
Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.
Website: https://en.avistonebio.com
Top Investors: Cathay Capital, Bain Capital, Vivo Capital, Primavera Capital Group, IDG Capital
Description:
Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.
Total Funding Amount:
$341M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Beijing, Beijing, China
Founded Date:
2011-01-01
Contact Email:
contact(AT)avistonebio.com
Founders:
Hepeng Shi
Number of Employees:
251-500
Last Funding Date:
2023-12-28
IPO Status:
Private
Industries:
© 2025 bioDAO.ai